Indian Journal of Neurosurgery 2015; 04(02): 069-073
DOI: 10.1055/s-0035-1558961
Original Article
Neurological Surgeons' Society of India

Prognostic Significance of Hyponatremia Leukocytosis, Hypomagnesemia, and Fever after Aneurysmal Subarachnoid Hemorrhage

Vrsajkov Vladimir
1   Clinical Centre of Vojvodina, Emergency Centre, Novi Sad, Serbia
,
Jovanović Gordana
2   Department of Anesthesia and Intensive Care, Clinical Centre of Vojvodina, Novi Sad, Serbia
,
Galešev Marija
2   Department of Anesthesia and Intensive Care, Clinical Centre of Vojvodina, Novi Sad, Serbia
,
Uvelin Arsen
1   Clinical Centre of Vojvodina, Emergency Centre, Novi Sad, Serbia
,
Glišić Dunja
1   Clinical Centre of Vojvodina, Emergency Centre, Novi Sad, Serbia
,
Pantić-Vrsajkov Jelena
3   Health Care Centre “Novi Sad,” Novi Sad, Serbia
› Author Affiliations
Further Information

Publication History

09 April 2015

25 May 2015

Publication Date:
28 July 2015 (online)

Abstract

Background Early identification of patients at an increased risk for delayed cerebral ischemia (DCI) and poor outcome could allow more aggressive therapy and influence better outcome. The aim of this study was to determine a predictive association of hyponatremia, hypomagnesemia, fever, and leukocytosis with DCI and poor outcome.

Patients and Methods We prospective enrolled 68 patients with subarachnoid hemorrhage (SAH) treated from March 2011 to May 2013. Serum levels of sodium, magnesium, and leukocyte count were determined at least once a day during the first 10 days after SAH. All patients underwent noncontrast computed tomography (CT) scan 9 ± 2 days after SAH. DCI was defined as one or more of the next parameters: a new focal neurological deficit, decline for two or more points on the modified Glasgow Coma Scale or a new hypodensity on CT scan. The outcome was assessed after 6 months using the extended Glasgow Outcome scale.

Results Overall, 48% of the patients recruited had DCI. Ramachandraiah logistic regression model showed significant impact of hyponatremia (p = 0.036; odds ratio [OR] = 4.08; 95% confidence interval [CI] = 1.09–15.26) on DCI and poor outcome (p = 0.034; OR = 5.11; 95% CI = 1.13–23.14). We obtained strong correlation of leukocytosis (p = 0.013) with DCI and poor outcome (p = 0.016). Association of noninfectious fever and hypomagnesemia with DCI existed, but it was not significant enough.

Conclusion Our results confirmed the association of hyponatremia and leukocytosis with greater risk of developing DCI and poor clinical outcome.

Note

This article contains original unpublished work, not being submitted for publication elsewhere. Submission of the article has been approved by the authorities from University hospital and Clinical center Novi Sad, Serbia. The authors declare that there is no conflict of interests regarding the publication of this article. This is a joint statement of all the listed authors.


 
  • References

  • 1 Harrod CG, Bendok BR, Batjer HH. Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: a review. Neurosurgery 2005; 56 (4) 633-654 , discussion 633–654
  • 2 Lazaridis C, Naval N. Risk factors and medical management of vasospasm after subarachnoid hemorrhage. Neurosurg Clin N Am 2010; 21 (2) 353-364
  • 3 Qureshi AI, Suri MF, Sung GY , et al. Prognostic significance of hypernatremia and hyponatremia among patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 2002; 50 (4) 749-755 , discussion 755–756
  • 4 Chandy D, Sy R, Aronow WS, Lee WN, Maguire G, Murali R. Hyponatremia and cerebrovascular spasm in aneurysmal subarachnoid hemorrhage. Neurol India 2006; 54 (3) 273-275
  • 5 Vrsajkov V, Javanović G, Stanisavljević S, Uvelin A, Vrsajkov JP. Clinical and predictive significance of hyponatremia after aneurysmal subarachnoid hemorrhage. Balkan Med J 2012; 29 (3) 243-246
  • 6 Levine JM. Critical care management of subarachnoid hemorrhage. Curr Treat Options Neurol 2009; 11 (2) 126-136
  • 7 Hasan D, Wijdicks EF, Vermeulen M. Hyponatremia is associated with cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. Ann Neurol 1990; 27 (1) 106-108
  • 8 Wartenberg KE, Schmidt JM, Claassen J , et al. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med 2006; 34 (3) 617-623 , quiz 624
  • 9 Zheng B, Qiu Y, Jin H , et al. A predictive value of hyponatremia for poor outcome and cerebral infarction in high-grade aneurysmal subarachnoid haemorrhage patients. J Neurol Neurosurg Psychiatry 2011; 82 (2) 213-217
  • 10 Saleh A, Megahed M, Ibrahim K. Hypomagnesemia, Hyponatremia And Hypercholesterolemia On Admission As Prognostic Predictors For Patients With Subarachinoid Haemorrhage. The Internet Journal of Interventional Medicine. 2010; 1 (1) 59-69
  • 11 van den Bergh WM, Algra A, van der Sprenkel JW, Tulleken CA, Rinkel GJ. Hypomagnesemia after aneurysmal subarachnoid hemorrhage. Neurosurgery 2003; 52 (2) 276-281 , discussion 281–282
  • 12 Collignon FP, Friedman JA, Piepgras DG , et al. Serum magnesium levels as related to symptomatic vasospasm and outcome following aneurysmal subarachnoid hemorrhage. Neurocrit Care 2004; 1 (4) 441-448
  • 13 Mahdi Z, Saberi H, Tabatabaei FSA, Tayebi MA, Habibi Z. Serum magnesium levels and clinical outcome of aneurysmal subarachnoid hemorrhage: a study in 60 patients. Tehran Univ Med J 2008; 66 (1) 7-11
  • 14 McMahon CJ, Hopkins S, Vail A , et al. Inflammation as a predictor for delayed cerebral ischemia after aneurysmal subarachnoid haemorrhage. J Neurointerv Surg 2013; 5 (6) 512-517
  • 15 McGirt MJ, Mavropoulos JC, McGirt LY , et al. Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2003; 98 (6) 1222-1226
  • 16 Choi JH, Moon JG, Lee HK, Hwang DY, Kim CH, Choi JH. Correlation between Symptomatic Vasospasm and Leukocyte, Platelet Count Following Aneurysmal Subarachnoid Hemorrhage: Clinical Research. Korean J Cerebrovasc Surg. 2007; 9 (2) 135-142
  • 17 Van Assche E, De Deyne C, Schneider I, Vander Laenen M, Heylen R. Early leukocytosis occurring after subarachnoid hemorrhage could be used as a predictor of later cerebral vasospasm: A-349. European J Anaesthesilogy 2006; 23: 9216
  • 18 Oliveira-Filho J, Ezzeddine MA, Segal AZ , et al. Fever in subarachnoid hemorrhage: relationship to vasospasm and outcome. Neurology 2001; 56 (10) 1299-1304
  • 19 Douds GL, Tadzong B, Agarwal AD, Krishnamurthy S, Lehman EB, Cockroft KM. Influence of Fever and hospital-acquired infection on the incidence of delayed neurological deficit and poor outcome after aneurysmal subarachnoid hemorrhage. Neurol Res Int 2012; 2012: 479865
  • 20 Jennett B, Snoek J, Bond MR, Brooks N. Disability after severe head injury: observations on the use of the Glasgow Outcome Scale. J Neurol Neurosurg Psychiatry 1981; 44 (4) 285-293
  • 21 Connolly Jr ES, Rabinstein AA, Carhuapoma JR , et al; American Heart Association Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke 2012; 43 (6) 1711-1737
  • 22 Ramachandraiah V, Chandy D. Hyponatremia and Cerebrovascular Spasm in Aneurysmal Subarachnoid Hemorrhage. Chest 2012; 142 (4) 371A
  • 23 Dhar R, Diringer MN. The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage. Neurocrit Care 2008; 8 (3) 404-412
  • 24 Naidech AM, Bendok BR, Bernstein RA , et al. Fever burden and functional recovery after subarachnoid hemorrhage. Neurosurgery 2008; 63 (2) 212-217 , discussion 217–218